Status:
COMPLETED
Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction
Lead Sponsor:
Mahidol University
Conditions:
Nasal Obstruction Present Finding
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Background Allergic rhinitis is a common health problem with a worldwide prevalence is 10-25%, and poses significant impact on the quality of life of the patients. In Thailand, the prevalence of aller...
Detailed Description
All participants will continue medications for 4 weeks, then stop using interventional medication and still take INS (2 puffs in each nostril twice daily) and OAH (1 tablet once daily) for 2 more week...
Eligibility Criteria
Inclusion
- Patient 18 years of age or greater
- Diagnosis with allergic or nonallergic rhinitis with persistent nasal obstruction
- Being treated with intranasal steroid and oral antihistamine
Exclusion
- Underlying disease of hypertension
- Use oral or nasal decongestant 7 days prior to entering the study
- Nasal polyp or significant deviated nasal septum
- Respiratory tract infection 14 days prior to entering the study
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01847131
Start Date
April 1 2013
End Date
December 1 2014
Last Update
January 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, Bangkok, Thailand, 10700